Literature DB >> 10978030

Neuroimaging in deteriorating patients with cerebellar infarcts and mass effect.

M G Koh1, T G Phan, J L Atkinson, E F Wijdicks.   

Abstract

BACKGROUND AND
PURPOSE: The decision to proceed with surgery in cerebellar infarct with mass effect (CIMASS) in deteriorating patients is based on clinical features. The potential role of neuroimaging in predicting deterioration has not been systematically studied. In this study we determine the role of neuroimaging in predicting deterioration in CIMASS.
METHODS: -We retrospectively reviewed the clinical and neuroimaging features in 90 patients with cerebellar infarcts. We selected for detailed analysis CIMASS in 35 patients.
RESULTS: Eighteen patients remained stable and 17 deteriorated. Of these 17 patients, 8 were treated conservatively and 9 had surgery. Radiological features indicative of progression were more common in deteriorating patients compared with stable patients: fourth ventricular shift (82.3% versus 50%, P:=0.075, OR=4. 67), hydrocephalus (76.5% versus 11.1%, P:=0.0001, OR=26), brain stem deformity (47% versus 5.6%, P:=0.0065, OR=15.1), and basal cistern compression (35.3% versus 0%, P:=0.0076, OR=20.91). Differences in upward displacement of the aqueduct and pontomesencephalic junction from Twining's line, tonsillar descent on sagittal MRI, and infarct volumes between stable and deteriorating patients were not statistically significant.
CONCLUSIONS: Hydrocephalus, brain stem deformity, and basal cistern compression may herald deterioration in CIMASS. Admission to a neurological-neurosurgical intensive care unit and consideration of preemptive surgery are warranted in these patients. Vertical displacement of tonsils or aqueduct, demonstrated by MR imaging, did not predict deterioration.

Entities:  

Mesh:

Year:  2000        PMID: 10978030     DOI: 10.1161/01.str.31.9.2062

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Stroke among patients with dizziness, vertigo, and imbalance in the emergency department: a population-based study.

Authors:  Kevin A Kerber; Devin L Brown; Lynda D Lisabeth; Melinda A Smith; Lewis B Morgenstern
Journal:  Stroke       Date:  2006-08-31       Impact factor: 7.914

2.  Treatment of malignant brain edema and increased intracranial pressure after stroke.

Authors:  Michael E Brogan; Edward M Manno
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

Review 3.  Care of the stroke patient: routine management to lifesaving treatment options.

Authors:  George A Lopez; Arash Afshinnik; Owen Samuels
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

4.  Treatment of cerebellar masses.

Authors:  Mahmut Edip Gurol; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

5.  Prediction of poor outcome in cerebellar infarction by diffusion MRI.

Authors:  Zahari Tchopev; Marc Hiller; Jiachen Zhuo; Joshua Betz; Rao Gullapalli; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

Review 6.  Use of perfusion imaging and other imaging techniques to assess risks/benefits of acute stroke interventions.

Authors:  Jason Tarpley; Dan Franc; Aaron P Tansy; David S Liebeskind
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

Review 7.  Imaging spectrum of cerebellar pathologies: a pictorial essay.

Authors:  Richa Arora
Journal:  Pol J Radiol       Date:  2015-03-16

8.  Risk Factors for Multiple Organ Dysfunction Syndrome in Severe Stroke Patients.

Authors:  Wei Qin; Xiaoyu Zhang; Shuna Yang; Yue Li; Junliang Yuan; Lei Yang; Shujuan Li; Wenli Hu
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

9.  A case of acute acquired obstructive hydrocephalus in a cat with suspected ischaemic cerebellar infarct.

Authors:  Francesca Raimondi; Filipa Lourinho; Harry Scott; Nadia Shihab
Journal:  JFMS Open Rep       Date:  2017-04-10

10.  Neuro-otological aspects of cerebellar stroke syndrome.

Authors:  Hyung Lee
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.